Hydrogen Inhalation Helps Gallbladder Cancer Patient Achieve Remission
<p>A Gallbladder Carcinoma Patient With Pseudo-Progressive Remission After Hydrogen Inhalation</p>
Research hubs: Digestive System · Immune System
- Evidence type
- Case report or series · Human study
- Authors
- Ji-Bing Chen, Feng Mu, Tianyu Lu, Yangyang Ma, Duanming Du, Ke-Cheng Xu
- Journal
- OncoTargets and Therapy
- Year
- 2019
- DOI
- 10.2147/OTT.S227217
- Study Type
- Human
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Gallbladder Carcinoma
- Body System
- Digestive System
TL;DR
Inhaling hydrogen gas helped a patient with advanced gallbladder cancer by initially making the tumors look worse before they actually started to shrink, leading to an improvement in the patient's health and prolonged survival.
Key Finding
A patient with metastatic gallbladder cancer experienced initial tumor growth followed by sustained remission after hydrogen inhalation therapy, a pattern similar to pseudo-progression seen with PD-1 immunotherapy drugs.
Summary
A 72-year-old woman with advanced gallbladder cancer that had spread to other organs received hydrogen gas therapy along with standard supportive care. Initially, her tumors appeared to grow larger and tumor markers (blood tests indicating cancer activity) increased, but then the tumors began shrinking over the following weeks. Her symptoms improved, blood counts normalized, and she was able to return to normal activities for over 10 months. This pattern—where tumors temporarily appear worse before improving—resembles what sometimes happens with certain cancer immunotherapy drugs.
Practical Takeaway
This is a single case report, not a controlled study, so it cannot establish whether hydrogen therapy caused the improvement or whether this would occur in other patients. The authors suggest hydrogen may affect immune cell function in ways similar to established cancer drugs, but this remains speculative. Much more rigorous research would be needed before drawing any conclusions about hydrogen's role in cancer treatment.
Abstract (excerpt)
Background: Hydrogen therapy has been reported to convert exhausted programmed cell death receptor (PD-1)+CD8+ T cells to PD-1-CD8+ T cells, in advanced colorectal cancer patients, which is associated with significantly prolonged survival. Case presentation: A 72-year-old female patient presented…